Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Change in Cash (2016 - 2025)

Historic Change in Cash for vTv Therapeutics (VTVT) over the last 12 years, with Q3 2025 value amounting to $72.6 million.

  • vTv Therapeutics' Change in Cash rose 193519.6% to $72.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.9 million, marking a year-over-year increase of 7080.07%. This contributed to the annual value of $27.3 million for FY2024, which is 111865.67% up from last year.
  • Per vTv Therapeutics' latest filing, its Change in Cash stood at $72.6 million for Q3 2025, which was up 193519.6% from -$5.1 million recorded in Q2 2025.
  • vTv Therapeutics' Change in Cash's 5-year high stood at $72.6 million during Q3 2025, with a 5-year trough of -$6.7 million in Q2 2024.
  • In the last 5 years, vTv Therapeutics' Change in Cash had a median value of -$2.5 million in 2022 and averaged $4.9 million.
  • Its Change in Cash has fluctuated over the past 5 years, first plummeted by 49942.05% in 2024, then soared by 193519.6% in 2025.
  • Quarter analysis of 5 years shows vTv Therapeutics' Change in Cash stood at -$6.2 million in 2021, then surged by 47.76% to -$3.2 million in 2022, then surged by 137.6% to $1.2 million in 2023, then plummeted by 499.42% to -$4.8 million in 2024, then skyrocketed by 1604.29% to $72.6 million in 2025.
  • Its last three reported values are $72.6 million in Q3 2025, -$5.1 million for Q2 2025, and -$5.7 million during Q1 2025.